Download PDF
Onkologische Welt 2013; 04(04): 157-161
DOI: 10.1055/s-0038-1629928
Hämato-Onkologie
Schattauer GmbH

Effects of exercise on psychosocial outcomes in patients undergoing hematopoietic stem cell transplantation

Effekte von körperlichem Training auf die psychosoziale Konstitution von Patienten unter allogener hämatopoetischer Stammzelltransplantation
J. Wiskemann
1   Divisions of Medical Oncology and Preventive Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
05 February 2018 (online)

    Permissions and Reprints

Summary

Hematopoietic stem cell transplantation (HSCT) is an intense treatment to cure patients from leukemia or lymphoma. Prior, during, and after the transplantation procedure patients experience considerable physical, psychological and psychosocial distress. In light of the increasing number of successfully treated patients the need is growing for evidence-based adjuvant therapy options, which reduce treatment-related side effects and enhance the rehabilitation process. Due to its multidimensional effectiveness physical exercise might be a suitable intervention to counteract with HSCT-related side-effects. Twenty-nine publications could be detected within a systematic literature search. The studies suggest that exercise training is an important therapeutic approach in the supportive care for HSCT patients. Significant benefits from the exercise interventions have been reported for physical performance and psychosocial parameter like quality of life (QoL), fatigue status and distress. Several other benefits, such as a more rapid immune recovery or alleviation of therapy-related side effects have been reported in some studies. Future studies should address existing methodological problems, identify further effect levels of physical exercise therapy and integrate a long-term perspective for the participants in the context of HSCT.

Zusammenfassung

Die hämatopoetische Stammzelltransplantation (HSCT) stellt eines der intensivsten Therapieverfahren in der Onkologie zur Behand-lung von Leukämie und Lymphomerkrankungen dar. Vor, während und nach HSCT treten bei zahlreichen Patienten physische, psychische und soziale Komplikationen auf. Mit Blick auf die zunehmende Zahl erfolgreich behandelter Patienten, steigt der Bedarf an evidenz-basierten Supportivtherapien, die in der Lage sind, behandlungsbedingten Nebenwirkungen entgegenzuwirken und den Rehabilitationsprozess zu unterstützen. Aufgrund der multidimensionalen Wirkung von körperlichem Training scheinen bewegungstherapeutische Ansätze hier vielversprechend zu sein.

Im Rahmen einer systematischen Literaturrecherche konnten insgesamt 29 Publikationen identifiziert werden, die sich mit dem Thema körperliches Training und Stammzelltrans-plantation auseinandersetzten. Die eingeschlossenen Studien zeigen, dass bewegungstherapeutische Maßnahmen einen wichtigen Beitrag zu Bekämpfung therapieassoziierter Nebenwirkungen darstellen. So konnten signifikante Effekte auf die körperliche Leistungsfähigkeit, psychosoziale Aspekte (bspw. Lebensqualität und Fatigue) und weitere therapiebedingte Nebenwirkungen nachgewiesen werden. Erste Studien lassen zudem auch Einflüsse auf das Immunsystem vermuten. Zukünftig sind qualitativ hochwertige Studien nötig um derzeit noch vorhandene methodische Mängel zu beheben, weitere Wirkpotentiale und Lang-zeiteffekt von körperlichem Training zu untersuchen.

Keywords

Cancer - stem cell transplantation - exercise - psychosocial distress

Schlüsselwörter

Krebs - Stammzelltransplantation - körperliches Training - psychosoziale Belastung
 

  • References

  • 1 Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354 (17) 1813-1826.
    CrossrefPubMedGoogle Scholar
  • 2 Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC. Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41 (11) 965-969.
    CrossrefPubMedGoogle Scholar
  • 3 Morishita S, Kaida K, Ikegame K, Yoshihara S, Taniguchi K, Okada M. et al. Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. Support Care Cancer 2012; 20 (04) 821-829.
    CrossrefPubMedGoogle Scholar
  • 4 Baker F, Zabora J, Polland A, Wingard J. Reintegration after bone marrow transplantation. Cancer Pract 1999; 7 (04) 190-197.
    CrossrefPubMedGoogle Scholar
  • 5 Danaher EH, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J. et al. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 2006; 33 (03) 614-624.
    CrossrefPubMedGoogle Scholar
  • 6 Mock V, Pickett M, Ropka ME, Muscari Lin E, Stewart KJ, Rhodes VA. et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer practice 2001; 9 (03) 119-127.
    CrossrefPubMedGoogle Scholar
  • 7 Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B. et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2008; 42 (12) 819-827.
    CrossrefPubMedGoogle Scholar
  • 8 Andrykowski MA, Bishop MM, Hahn EA, Cella DF, Beaumont JL, Brady MJ. et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23 (03) 599-608.
    CrossrefPubMedGoogle Scholar
  • 9 Pidala J, Anasetti C, Jim H. Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention. Br J Haematol 2009; 148 (03) 373-385.
    PubMedGoogle Scholar
  • 10 Baker KS, Ness KK, Weisdorf D, Francisco L, Sun CL, Forman S. et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Leukemia. 2010; 24 (12) 2039-2047.
    CrossrefPubMedGoogle Scholar
  • 11 Tichelli A, Passweg J, Wojcik D, Rovo A, Harousseau JL, Masszi T. et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 2008; 93 (08) 1203-1210.
    CrossrefPubMedGoogle Scholar
  • 12 Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L. A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 2009; 43 (09) 725-737.
    CrossrefPubMedGoogle Scholar
  • 13 Jarden M, Nelausen K, Hovgaard D, Boesen E, Adamsen L. The effect of a multimodal intervention on treatment-related symptoms in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial. Journal of pain and symptom management. 2009; 38 (02) 174-190.
    CrossrefPubMedGoogle Scholar
  • 14 Baumann FT, Kraut L, Schule K, Bloch W, Fauser AA. A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 2010; 45 (02) 355-362.
    CrossrefPubMedGoogle Scholar
  • 15 Baumann FT, Zopf EM, Nykamp E, Kraut L, Schule K, Elter T. et al. Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol. 2011; 87 (02) 148-156.
    CrossrefPubMedGoogle Scholar
  • 16 Wiskemann J, Dreger P, Schwerdtfeger R, Bondong A, Huber G, Kleindienst N. et al. Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood 2011; 117 (09) 2604-2613.
    CrossrefPubMedGoogle Scholar
  • 17 Hayes S, Davies PS, Parker T, Bashford J, Newman B. Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate-intensity, exercise program. Bone Marrow Transplant 2004; 33 (05) 553-558.
    CrossrefPubMedGoogle Scholar
  • 18 Wilson RW, Jacobsen PB, Fields KK. Pilot study of a home-based aerobic exercise program for sedentary cancer survivors treated with hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35 (07) 721-727.
    CrossrefPubMedGoogle Scholar
  • 19 Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F. et al. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplant 2011; 46 (09) 1245-1255.
    CrossrefPubMedGoogle Scholar
  • 20 DeFor T, Burns L, Gold E, Weisdorf D. A Randomized Trial of the Effekt of a Walking Regimen on the Functional Status of 100 Adult Allogeneic Donor Hematopoietic Cell Transplant Patients. Biology of Blood and Marroww Transplantation 2007; 13: 948-955.
    Google Scholar
  • 21 Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999; 85 (10) 2273-2277.
    CrossrefPubMedGoogle Scholar
  • 22 Carlson LE, Smith D, Russell J, Fibich C, Whittaker T. Individualized exercise program for the treatment of severe fatigue in patients after allogeneic hematopoietic stem-cell transplant: a pilot study. Bone Marrow Transplant 2006; 37 (10) 945-954.
    CrossrefPubMedGoogle Scholar
  • 23 Hacker ED, Larson J, Kujath A, Peace D, Rondelli D, Gaston L. Strength Training Following Hematopoietic Stem Cell Transplantation. Cancer Nurs 2011; 34 (03) 238-490.
    CrossrefPubMedGoogle Scholar
  • 24 Coleman EA, Coon S, Hall-Barrow J, Richards K, Gaylor D, Stewart B. Feasibility of exercise during treatment for multiple myeloma. Cancer Nurs 2003; 26 (05) 410-419.
    CrossrefPubMedGoogle Scholar
  • 25 Dimeo F, Fetscher S, Lange W, Mertelsmann R, Keul J. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 1997; 90 (09) 3390-3394.
    PubMedGoogle Scholar
  • 26 Dimeo F, Bertz H, Finke J, Fetscher S, Mertelsmann R, Keul J. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant 1996; 18 (06) 1157-1160.
    PubMedGoogle Scholar
  • 27 Hayes SC, Davies PS, Parker TW, Bashford J, Green A. Role of a mixed type, moderate intensity exercise programme after peripheral blood stem cell transplantation. BrJSports Med 2004; 38 (03) 304-9.
    Google Scholar
  • 28 Dimeo FC, Tilmann MH, Bertz H, Kanz L, Mertelsmann R, Keul J. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 1997; 79 (09) 1717-1722.
    CrossrefPubMedGoogle Scholar
  • 29 Mello M, Tanaka C, Dulley FL. Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 2003; 32 (07) 723-728.
    CrossrefPubMedGoogle Scholar
  • 30 Hayes S, Davies PS, Parker T, Bashford J. Total energy expenditure and body composition changes following peripheral blood stem cell transplantation and participation in an exercise programme. Bone Marrow Transplant 2003; 31 (05) 331-338.
    CrossrefPubMedGoogle Scholar
  • 31 Cunningham BA, Morris G, Cheney CL, Buergel N, Aker SN, Lenssen P. Effects of resistive exercise on skeletal muscle in marrow transplant recipients receiving total parenteral nutrition. JPEN JParenterEnteral Nutr 1986; 10 (06) 558-563.
    Google Scholar
  • 32 Kim SD, Kim HS. A series of bed exercises to improve lymphocyte count in allogeneic bone marrow transplantation patients. EurJCancer Care (Engl) 2006; 15 (05) 453-457.
    Google Scholar
  • 33 Hayes SC, Rowbottom D, Davies PS, Parker TW, Bashford J. Immunological changes after cancer treatment and participation in an exercise program. MedSciSports Exerc 2003; 35 (01) 2-9.
    Google Scholar
  • 34 DeFor TE, Burns LJ, Gold EM, Weisdorf DJ. A randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients. BiolBlood Marrow Transplant 2007; 13 (08) 948-955.
    Google Scholar